Form 4: VolitionRx Ltd. Executive Receives Stock Award in Lieu of Cash Compensation

Rodney Gerard Rootsaert, a Secretary at VolitionRx Ltd., received 7,302 restricted stock units in lieu of cash compensation.

Summary

• Rodney Gerard Rootsaert, a Secretary at VolitionRx Ltd., was awarded 7,302 restricted stock units (RSUs) on December 1, 2024.
• These RSUs were granted in place of cash compensation that would have otherwise been owed to Mr. Rootsaert.
• The RSUs vest in three equal installments of 2,434 units on December 1, 2024, January 1, 2025, and February 1, 2025.
• A further single installment of vesting is scheduled for July 1, 2025.
• Vesting is contingent upon continued service throughout each applicable vesting date.
• Upon vesting, Mr. Rootsaert will receive common stock equal to the number of vested RSUs.
• Mr. Rootsaert also indirectly owns 1,007,718 shares of common stock through Concord International, Inc., where he is a controlling director.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally positive for aligning executive and shareholder interests. There are no negative implications.

Positives

• The award of RSUs aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages continued service from the executive.

Future Outlook

The executive will receive shares of common stock upon the vesting of the RSUs, subject to continued service.

Industry Context

The granting of stock-based compensation is a common practice in the biotechnology industry to incentivize executives and align their interests with shareholders.

Comparison to Industry Standards

• Stock-based compensation is a standard practice across the biotechnology industry, with companies like Exact Sciences (EXAS) and Guardant Health (GH) also using RSUs and stock options to compensate executives.
• The vesting schedule of the RSUs is typical, with time-based vesting over a period of months or years to encourage long-term commitment.
• The amount of RSUs granted is not unusual for a company of VolitionRx's size and stage of development.

Stakeholder Impact

• Shareholders may view the RSU award as a positive incentive for the executive.
• Employees may see this as a standard practice for executive compensation.

Key Dates

Keywords

restricted stock units, RSUs, stock compensation, insider trading, executive compensation, beneficial ownership, VolitionRx Ltd, VNRX